SAB Biotherapeutics

0 followers


SAB Biotherapeutics is advancing a new class of immunotherapies with targeted, fully human polyclonal antibodies for the treatment of Covid-19, diabetes, organ transplant & flu.

Industries

Employees

51-200

Links

Org chart

Eddie J. Sullivan
Co-Founder, President & CEO

Eddie J. Sullivan

Collapse
Christoph Bausch
Executive Vice President & Chief Operating Officer
Alexandra Kropotova
EVP, Chief Medical Officer
Dr. Carlos Carrillo, MS, PhD.
SVP Of Regulatory Affairs/quality Assurance At SAB Biotherapeutics
Jacob Spade
Senior Director Human Resources
Angela Parizek
Vice President, Clinical Operations
Trenton Klimper
Executive Director of Financial Reporting
Katie Ellias
Board Member
Lucy To
Chief Financial Officer